Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel Group, Phase III Randomized, Modified Double-blind, Active Controlled Study to Investigate the Immunogenicity and Safety of vYF Compared to Licensed YF Vaccines in Pediatric Population Aged 9 Months to 5 Years of Age

NCT07103148 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07103148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07103148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel Group, Phase III Randomized, Modified Double-blind, Active Controlled Study to Investigate the Immunogenicity and Safety of vYF Compared to Licensed YF Vaccines in Pediatric Population Aged 9 Months to 5 Years of Age
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Recruiting
Start date
July 11, 2025
Completion date
March 4, 2030
Enrollment
2,440 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

yellow fever immunization